Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine?

Abstract

Pediatric Blood & CancerVolume 54, Issue 5 p. 781-782 Letter to the Editor Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine? Emilie Moreau, Emilie Moreau Pediatric Resident, Pediatric Oncology Department, Children's Hospital of “La Timone,” AP-HM, Marseille, FranceSearch for more papers by this authorNicolas André MD, PhD, Corresponding Author Nicolas André MD, PhD nicolas.andre@ap-hm.fr Pediatric Resident, Pediatric Oncology Department, Children's Hospital of “La Timone,” AP-HM, Marseille, France UMR-777 INSERM, Cytosquelette et Intégration des Signaux du Micro-Environnement Tumoral (CISMET), CRO2, Aix-Marseille University, Marseille, FrancePediatric Oncology Department, Children's Hospital of “La Timone,” AP-HM, Bd Jean Moulin, 13885 Marseille Cedex 5, France.===Search for more papers by this authorCarole Coze MD, PhD, Carole Coze MD, PhD Pediatric Resident, Pediatric Oncology Department, Children's Hospital of “La Timone,” AP-HM, Marseille, FranceSearch for more papers by this authorLaetitia Padovani MD, Laetitia Padovani MD Department of Radiation Therapy, Hôpital de la Timone, AP-HM, Marseille, FranceSearch for more papers by this authorCedric Mercier MD, PhD, Cedric Mercier MD, PhD UMR-MD3, Pharmacokinetics Unit, Aix-Marseille University, Marseille, FranceSearch for more papers by this authorJoseph Ciccolini PharmD, PhD, Joseph Ciccolini PharmD, PhD UMR-MD3, Pharmacokinetics Unit, Aix-Marseille University, Marseille, FranceSearch for more papers by this author Emilie Moreau, Emilie Moreau Pediatric Resident, Pediatric Oncology Department, Children's Hospital of “La Timone,” AP-HM, Marseille, FranceSearch for more papers by this authorNicolas André MD, PhD, Corresponding Author Nicolas André MD, PhD nicolas.andre@ap-hm.fr Pediatric Resident, Pediatric Oncology Department, Children's Hospital of “La Timone,” AP-HM, Marseille, France UMR-777 INSERM, Cytosquelette et Intégration des Signaux du Micro-Environnement Tumoral (CISMET), CRO2, Aix-Marseille University, Marseille, FrancePediatric Oncology Department, Children's Hospital of “La Timone,” AP-HM, Bd Jean Moulin, 13885 Marseille Cedex 5, France.===Search for more papers by this authorCarole Coze MD, PhD, Carole Coze MD, PhD Pediatric Resident, Pediatric Oncology Department, Children's Hospital of “La Timone,” AP-HM, Marseille, FranceSearch for more papers by this authorLaetitia Padovani MD, Laetitia Padovani MD Department of Radiation Therapy, Hôpital de la Timone, AP-HM, Marseille, FranceSearch for more papers by this authorCedric Mercier MD, PhD, Cedric Mercier MD, PhD UMR-MD3, Pharmacokinetics Unit, Aix-Marseille University, Marseille, FranceSearch for more papers by this authorJoseph Ciccolini PharmD, PhD, Joseph Ciccolini PharmD, PhD UMR-MD3, Pharmacokinetics Unit, Aix-Marseille University, Marseille, FranceSearch for more papers by this author First published: 04 March 2010 https://doi.org/10.1002/pbc.22427Citations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume54, Issue5May 2010Pages 781-782 RelatedInformation